MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Measuring perceived-health status in Parkinson’s Disease – the role of London Handicap Scale

    D. Silva, M. Coelho, T. Soares, T. Vale, L. Guedes, R. Maciel, A. Antunes, S. Camargos, A. Valadas, C. Godinho, D. Maia, P. Lobo, R. Maia, T. Teodoro, C. Rieder, A. Velon, M. Rosas, A. Calado, V. Caniça, F. Cardoso, J. Ferreira (Lisbon, Portugal)

  • Measuring progression of nigrostriatal degeneration in Parkinson’s disease using 18F-AV-133 vesicular monoamine transporter type-2 (VMAT2) PET

    S. Xu, V. Dore, P. Alexander, Y. Lie, S. Bozinovski, R. Mulligan, K. Young, V. Villemagne, C. Rowe (Melbourne, Australia)

  • Mechanism-based classification in PD cohorts

    B. Labrador, F. Danjou, S. Bekadar, FX. Lejeune, H. Froehlich, M. Hofmann-Apitius, JC. Corvol (Paris, France)

  • Mechanisms underlying therapeutic group singing in persons with Parkinson’s disease

    E. Stegemoller, A. Zaman, K. Diaz, E. Shirtcliff, M. Kohut (Ames, IA, USA)

  • Medical and Device-Guided Therapies and Deep Brain Stimulation in Parkinson’s disease: Experience of a Tertiary Centre from Turkey

    Y. Sucullu Karadag, D. Divanlıoglu, E. Kocabicak, N. Subutay Oztekin, D. Belen (Ankara, Turkey)

  • Medical evaluation as gold standard to control iPrognosis application derived data for early Parkinson’s disease detection

    L. Klingelhoefer, S. Bostanjopoulou, D. Trivedi, S. Hadjidimitriou, S. Mayer, Z. Katsarou, V. Charisis, M. Stadtschnitzer, S. Dias, G. Ntakakis, N. Grammalidis, K. Kyritsis, H. Jaeger, D. Iakovakis, I. Ioakeimidis, F. Karayiannis, J. Diniz, A. Delopoulos, L. Hadjileontiadis, H. Reichmann, K. Chaudhuri (Dresden, Germany)

  • Medical management after subthalamic nucleus deep brain stimulation in patients with Parkinson’s Disease

    A. Bertholo, R. Cury (São Paulo, Brazil)

  • Medical management of primary hemifacial spasm

    G. Kumar, D. Kaur, A. Singh (Patna, India)

  • Memantine and 3D gait analysis in patient with Parkinson’s disease: an observer-blind randomized clinical trial

    I. Miliukhina, E. Gracheva (Saint-Petersburg, Russian Federation)

  • Memantine induced dyskinesia in Alzheimer’s disease

    M. Kaiserova, L. Hvizdošova, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)

  • « Previous Page
  • 1
  • …
  • 121
  • 122
  • 123
  • 124
  • 125
  • …
  • 217
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley